Business Description
GlycoMimetics Inc
NAICS : 325412
SIC : 2834
ISIN : US38000Q1022
Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 49.57 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -19.79 | |||||
Beneish M-Score | -0.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 19.7 | |||||
3-Year FCF Growth Rate | 13.8 | |||||
3-Year Book Growth Rate | -38.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.08 | |||||
9-Day RSI | 48.46 | |||||
14-Day RSI | 38.25 | |||||
6-1 Month Momentum % | -89.76 | |||||
12-1 Month Momentum % | -83.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.28 | |||||
Quick Ratio | 6.28 | |||||
Cash Ratio | 5.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.5 | |||||
Shareholder Yield % | 0.68 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -394490 | |||||
Net Margin % | -372780 | |||||
FCF Margin % | -347211.11 | |||||
ROE % | -80.74 | |||||
ROA % | -70.75 | |||||
ROIC % | -952.92 | |||||
ROC (Joel Greenblatt) % | -4347.48 | |||||
ROCE % | -85.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 0.6 | |||||
EV-to-EBIT | 0.34 | |||||
EV-to-EBITDA | 0.34 | |||||
EV-to-Revenue | -1350.3 | |||||
EV-to-FCF | 0.4 | |||||
Price-to-Net-Current-Asset-Value | 0.61 | |||||
Price-to-Net-Cash | 0.66 | |||||
Earnings Yield (Greenblatt) % | 294.12 | |||||
FCF Yield % | -197.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlycoMimetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.009 | ||
EPS (TTM) (€) | -0.535 | ||
Beta | 1.83 | ||
Volatility % | 126.17 | ||
14-Day RSI | 38.25 | ||
14-Day ATR (€) | 0.023582 | ||
20-Day SMA (€) | 0.248 | ||
12-1 Month Momentum % | -83.69 | ||
52-Week Range (€) | 0.2165 - 3.19 | ||
Shares Outstanding (Mil) | 64.46 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GlycoMimetics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GlycoMimetics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
GlycoMimetics Inc Frequently Asked Questions
What is GlycoMimetics Inc(STU:GKO)'s stock price today?
The current price of STU:GKO is €0.26. The 52 week high of STU:GKO is €3.19 and 52 week low is €0.22.
When is next earnings date of GlycoMimetics Inc(STU:GKO)?
The next earnings date of GlycoMimetics Inc(STU:GKO) is 2024-08-02 Est..
Does GlycoMimetics Inc(STU:GKO) pay dividends? If so, how much?
GlycoMimetics Inc(STU:GKO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |